VACCINES AS A PRODUCT OF INDUSTRIAL BIOTECHNOLOGIES AND A SPECIAL COMMODITY IN THE INTERNATIONAL BIOPHARMACEUTICALS MARKET | Titova | International Trade and Trade Policy

International Trade and Trade Policy
Meždunarodnaâ torgovlâ i torgovaâ politika

ISSN 2410-7395 (Print)
ISSN 2414-4649 (Online)

eng | рус

Preview

International Trade and Trade Policy

Advanced search

Archives

Download this PDF file

For citations:

Titova E.S., Shishkin S.S. VACCINES AS A PRODUCT OF INDUSTRIAL BIOTECHNOLOGIES AND A SPECIAL COMMODITY IN THE INTERNATIONAL BIOPHARMACEUTICALS MARKET. International Trade and Trade Policy. 2023;9(3):87-100. (In Russ.) https://doi.org/10.21686/2410-7395-2023-3-87-100

Views PDF (Rus): 154

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2410-7395 (Print)
ISSN 2414-4649 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

E. S. Titova
Plekhanov Russian University of Economics
Russian Federation

Ekaterina S. Titova, PhD, Leading Researcher of the Education Development Research Institute of the PRUE

36 Stremyanny Lane, Moscow, 115054

S. S. Shishkin
Federal Research Centre “Fundamentals of biotechnology” of the Russian Academy of Sciences
Russian Federation

Sergey S. Shishkin, Doctor of Biological Sciences, Professor,
Senior Researcher of the Analytical Group of the Research Centre of Biotechnology RAS

33, Building 2, Leninsky Prospect, Moscow, 119071

Notifications